With Teva entering the next stage of its sweeping restructuring plan, thousands of employees are slated to be let go from the hybrid generics and innovative medicines giant. As part of a new bid ...

Teva Pharmaceutical Industries Limited (TEVA)’s share was trading at $16.89 as of May 14th. TEVA’s forward P/E is 6.47 according to Yahoo Finance. Teva Pharmaceuticals, the world’s largest ...

We recently published a list of Why These 10 Stocks Soared Today. In this article, we are going to take a look at where Teva Pharmaceutical Industries Limited (NYSE:TEVA) stands against other ...

Q1 adjusted EPS was $0.52, beating $0.48 estimates; Teva raised 2025 EPS outlook to $2.45–$2.65. Get access to the leaderboards pointing to tomorrow’s biggest stock movers. Teva Pharmaceutical ...

Shares of Teva Pharmaceutical (NYSE:TEVA) traded higher in the premarket on Wednesday after the generic drugmaker cited unfavorable forex movements as its revenue for the first quarter of 2025 ...

The analyst behind the change is now bullish on Teva's future. The person behind the modification was JPMorgan Chase analyst Chris Schott, who pushed up his Teva stock recommendation one notch ...

Teva reported Q1 earnings, beating Wall Street's EPS expectations. The company raised its full-year guidance as margins expand. Teva reported Q1 adjusted earnings per share (EPS) of $0.52, solidly ...

We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Substack by Kontra. In this article, we will summarize the bulls’ thesis on TEVA. Teva Pharmaceutical ...

Teva raised its full-year 2025 earnings guidance to $2.45-$2.65 per share, up from the previous outlook of $2.35-$2.65. The revenue forecast for 2025 was adjusted to $16.8-$17.2 billion ...

Teva Pharmaceuticals announced that Fitch Ratings has upgraded its corporate credit rating from BB to BB+, maintaining a stable outlook. This upgrade reflects Teva's efforts to reduce debt ...

Teva Pharmaceuticals and Alvotech announced that the Food and Drug Administration has approved Selarsdi (ustekinumab-aekn) injection as interchangeable with Stelara (ustekinumab). As of April 30 ...

A team of trekkers from Mysuru, comprising children of pourakarmikas, returned to the city on Thursday, after they found themselves stranded in Amritsar owing to the cancellation of flights on ...